An address associated with the Ethereum Foundation deposited 5,748 ETH to an exchange

Eton Pharmaceuticals, Inc. announced that, in addition to the acquisition of core assets, the company also plans to purchase approximately $1.5 million worth of inventory products at the time of transaction closing.

Eton Pharmaceuticals, Inc. has signed a licensing agreement to successfully acquire the exclusive U.S. marketing rights for Hemangeol oral solution from Pierre Fabre Medicament Sas.

While actively promoting a stock buyback program to narrow the net asset value discount, ProCap Financial recently completed a strategic acquisition of 450 bitcoins.

According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), healthcare giant Humana stated that its GAAP-based earnings per share (EPS) guidance for fiscal year 2026 may be adjusted due to the company's ongoing value creation plan and other strategic initiatives.